Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks-Reference-Cited by-全球学者库

Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks

Published:2012-07 Issue:7 Volume:36 Page:841-845
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Huang Hongming,Qin Yan,Xu Ruirong,You Xuefeng,Teng Rong,Yang Li,Xu Mengqi,Liu Hong

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Acute promyelocytic leukemia;Hillestad;Acta Med Scand,1957

2. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group;Fenaux;Blood,1999

3. All-trans-retinoic acid in acute promyelocytic leukemia;Tallman;N Engl J Med,1997

4. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups;Sanz;Blood,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines;Frontiers in Oncology;2022-12-01

2. Proteomic Profiling of HL-60 Cells during ATRA-Induced Differentiation;Bulletin of Experimental Biology and Medicine;2018-08

3. First-Line Therapy: ATRA-ATO/Reduced Chemotherapy Approach;Acute Promyelocytic Leukemia;2017-09-26

4. Combined chemotherapy for acute promyelocytic leukemia: a meta-analysis;Hematology;2017-05-07

5. Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE);International Journal of Hematology;2017-03-14